Sarah Rush

836 total citations
25 papers, 380 citations indexed

About

Sarah Rush is a scholar working on Genetics, Molecular Biology and Neurology. According to data from OpenAlex, Sarah Rush has authored 25 papers receiving a total of 380 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Genetics, 6 papers in Molecular Biology and 6 papers in Neurology. Recurrent topics in Sarah Rush's work include Glioma Diagnosis and Treatment (8 papers), Neuroblastoma Research and Treatments (5 papers) and Telemedicine and Telehealth Implementation (4 papers). Sarah Rush is often cited by papers focused on Glioma Diagnosis and Treatment (8 papers), Neuroblastoma Research and Treatments (5 papers) and Telemedicine and Telehealth Implementation (4 papers). Sarah Rush collaborates with scholars based in United States, South Africa and India. Sarah Rush's co-authors include Nicholas K. Foreman, Arthur Liu, Michael K. Cooper, Ty W. Abel, J. Gerardo Valadez, Andrew M. Donson, Diane K. Birks, Laura Z. Fenton, Reid C. Thompson and Neil L. McNinch and has published in prestigious journals such as Journal of Clinical Oncology, Oncogene and Journal of Neuropathology & Experimental Neurology.

In The Last Decade

Sarah Rush

22 papers receiving 376 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Sarah Rush United States 11 215 153 110 62 57 25 380
Margaret Dougherty United States 8 208 1.0× 128 0.8× 99 0.9× 38 0.6× 19 0.3× 9 348
Kee Kiat Yeo United States 10 193 0.9× 90 0.6× 156 1.4× 42 0.7× 60 1.1× 36 325
Anthony P. Y. Liu Hong Kong 12 210 1.0× 137 0.9× 106 1.0× 69 1.1× 36 0.6× 40 415
Lisa Shane United States 8 112 0.5× 98 0.6× 52 0.5× 26 0.4× 61 1.1× 14 283
Kathryn J. Robinson United Kingdom 6 399 1.9× 170 1.1× 223 2.0× 87 1.4× 35 0.6× 9 474
Olga Zheludkova Russia 7 201 0.9× 139 0.9× 113 1.0× 36 0.6× 21 0.4× 38 307
Isabella Mammi Italy 13 93 0.4× 113 0.7× 169 1.5× 54 0.9× 54 0.9× 29 551
Keita Terashima Japan 12 156 0.7× 88 0.6× 95 0.9× 41 0.7× 43 0.8× 39 328
David Samuel United States 9 190 0.9× 74 0.5× 106 1.0× 37 0.6× 62 1.1× 23 441
Carlo Cappelli Italy 9 197 0.9× 116 0.8× 294 2.7× 143 2.3× 47 0.8× 20 455

Countries citing papers authored by Sarah Rush

Since Specialization
Citations

This map shows the geographic impact of Sarah Rush's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sarah Rush with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sarah Rush more than expected).

Fields of papers citing papers by Sarah Rush

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sarah Rush. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sarah Rush. The network helps show where Sarah Rush may publish in the future.

Co-authorship network of co-authors of Sarah Rush

This figure shows the co-authorship network connecting the top 25 collaborators of Sarah Rush. A scholar is included among the top collaborators of Sarah Rush based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sarah Rush. Sarah Rush is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Pelletier, Jonathan H., Sarah Rush, Michael T. Bigham, et al.. (2025). Nirsevimab Administration and RSV Hospitalization in the 2024-2025 Season. JAMA Network Open. 8(9). e2533535–e2533535.
2.
Pelletier, Jonathan H., et al.. (2025). Effect of a generative artificial intelligence digital scribe on pediatric provider documentation time, cognitive burden, and burnout. JAMIA Open. 8(4). ooaf068–ooaf068. 4 indexed citations
3.
Nofziger, Ryan A., Michael T. Bigham, Michael L. Forbes, et al.. (2025). Association Between Caffeine and Invasive Mechanical Ventilation in Bronchiolitis-Related Apnea. 1(4). 1–10.
4.
Ostrowski, Sarah A., Neil L. McNinch, Daniel H. Grossoehme, et al.. (2022). Understanding Drivers of Telemedicine in Pediatric Medical Care. Telemedicine Journal and e-Health. 29(5). 726–737. 4 indexed citations
5.
Raina, Rupesh, Nikhil Nair, Ronith Chakraborty, et al.. (2021). Telemedicine for Pediatric Nephrology: Perspectives on COVID-19, Future Practices, and Work Flow Changes. Kidney Medicine. 3(3). 412–425. 5 indexed citations
6.
Raina, Rupesh, Nikhil Nair, Hui‐Kim Yap, et al.. (2021). Survey of Telemedicine by Pediatric Nephrologists During the COVID-19 Pandemic. Kidney International Reports. 6(9). 2316–2322. 13 indexed citations
7.
Nellan, Anandani, Erin Wright, Kristen Campbell, et al.. (2020). Retrospective analysis of combination carboplatin and vinblastine for pediatric low-grade glioma. Journal of Neuro-Oncology. 148(3). 569–575. 14 indexed citations
8.
McNinch, Neil L., et al.. (2019). Diagnostic delay and morbidity of central nervous system tumors in children and young adults: a pediatric hospital experience. Journal of Neuro-Oncology. 143(2). 297–304. 22 indexed citations
9.
Fuller, Christine, Daniel R. Boué, Diana S. Osorio, et al.. (2018). LGG-24. TEMPORAL GENOMIC HETEROGENEITY IN PEDIATRIC LOW-GRADE GLIOMAS. Neuro-Oncology. 20(suppl_2). i109–i109. 1 indexed citations
10.
Madden, Jennifer R., et al.. (2015). Benefits of Using an Early Palliative Care Intervention in Pediatric Oncology. Journal of Hospice and Palliative Nursing. 17(4). 319–324. 3 indexed citations
11.
Rush, Sarah, et al.. (2014). Pediatric posterior fossa ganglioglioma: unique MRI features and correlation with BRAF V600E mutation status. Journal of Neuro-Oncology. 118(2). 395–404. 23 indexed citations
12.
Madden, Jennifer R., Sarah Rush, Nicholas Stence, Nicholas K. Foreman, & Arthur K. Liu. (2013). Radiation-induced Gliomas in 2 Pediatric Patients With Neurofibromatosis Type 1. Journal of Pediatric Hematology/Oncology. 36(2). e105–e108. 4 indexed citations
13.
Barton, Valerie N., Andrew M. Donson, Diane K. Birks, et al.. (2013). Insulin-Like Growth Factor 2 mRNA Binding Protein 3 Expression Is an Independent Prognostic Factor in Pediatric Pilocytic and Pilomyxoid Astrocytoma. Journal of Neuropathology & Experimental Neurology. 72(5). 442–449. 17 indexed citations
14.
Rush, Sarah, Nicholas K. Foreman, & Arthur Liu. (2013). Brainstem Ganglioglioma Successfully Treated With Vemurafenib. Journal of Clinical Oncology. 31(10). e159–e160. 105 indexed citations
15.
Chan, Michael, B. K. Kleinschmidt‐DeMasters, Andrew M. Donson, et al.. (2012). Pediatric brainstem gangliogliomas show overexpression of neuropeptide prepronociceptin (PNOC) by microarray and immunohistochemistry. Pediatric Blood & Cancer. 59(7). 1173–1179. 17 indexed citations
16.
Rush, Sarah, Ty W. Abel, J. Gerardo Valadez, Matthew M. Pearson, & Michael K. Cooper. (2010). Activation of the Hedgehog pathway in pilocytic astrocytomas. Neuro-Oncology. 12(8). 790–798. 23 indexed citations
17.
Valadez, J. Gerardo, et al.. (2009). Targeted inhibition of the Hedgehog pathway in established malignant glioma xenografts enhances survival. Oncogene. 28(39). 3468–3476. 48 indexed citations
18.
Rush, Sarah, et al.. (1997). Professional development. Care planning: professional issues (continuing education credit).. PubMed. 92(38). Suppl 9–12; quiz suppl 13. 1 indexed citations
19.
Rush, Sarah, et al.. (1996). Professional development. Care planning: knowledge for practice (continuing education credit).. PubMed. 92(36). suppl 1–4.
20.
Rush, Sarah, et al.. (1993). Phenotypic characterization of the human fibrous histiocytoma giant cell tumor (GCT) cell line and its cytokine repertoire.. PubMed. 21(10). 1342–52. 18 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026